Buc-ee's founder Arch Aplin III is gifting $50M to A&M's new facility. Buc-ee's/Facebook

The founder of Lone Star State’s favorite rest stop/gas station/car wash/cultural beacon has just made a Texas-sized investment in a major state university.

Buc-ee’s mastermind Arch “Beaver” Aplin III will commit $50 million toward establishing a Texas A&M University academic center that will serve as an immersive learning laboratory, the school announced.

Dubbed the Aplin Center (Aplin graduated from A&M in 1980), the hub will offer new university programs in hospitality, retail studies, and food product development through degree programs including viticulture, fermentation processes, coffee, and food science.

This new facility also will house product development laboratories and food tasting centers that can be utilized in partnership with related industries, according to a press release. Retail and food services areas will be managed by students and faculty. Students can also expect indoor and outdoor recreational spaces.

The center will be built across the street from the Texas A&M Hotel and Conference Center near Wellborn Road and Kyle Field.

Aplin’s $50 million commitment marks one of the largest single donations in Texas A&M history. “Arch ‘Beaver’ Aplin is a true visionary and one of the most creative entrepreneurs I have known,” said school president Dr. M. Katherine Banks in a statement. “He remains connected to his university, speaking to many students who share his passion for business and product development. Through this generous gift, he is creating a living, learning laboratory that will provide transformational opportunities for our students. The Aplin Center will positively impact Aggies for generations to come.”

Buc-ee’s founder, in turn, noted that Banks’ vision of a “world-class hospitality entrepreneurship program” is “just what Texas A&M needs and I’m proud to have an opportunity to be involved.”

Two years after graduation, Aplin opened his first Buc-ee’s in 1982 in Lake Jackson. His beaver empire has since expanded into five other states, with development underway in another five. Aplin’s brand hallmarks include pristine restrooms, endless fuel pumps, a vast selection of food and consumer items.

Besides its reputation as a cult and customer favorite, Buc-ee’s offers health insurance to employees and pays more than twice the amount of minimum wage. Earlier this year, the convenience store-rest stop hybrid received nationwide attention on CBS Sunday Morning. July 28 marks Buc-ee’s 40th anniversary.

“When Beaver Aplin does something, it’s never halfway,” said A&M System chancellor John Sharp in a statement. “The love he has and shows for Texas A&M and Aggies is inspirational and appreciated. This is an awesome gift and will position Texas A&M to become the top hospitality program in the nation.”

An Aggie through and through, Aplin, who serves on myriad boards and is also chairman of Texas Parks and Wildlife, once preached the College Station gospel during a lecture in 2012, telling the class, “I have to remember — I’ve gotta stay Beaver. I’ve gotta stay Buc-ee’s. I’ve gotta stay Aggie and I’ve gotta stay who I am.”

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

Axiom Space tops $525M in oversubscribed round, announces Swiss subsidiary

funding boost

Axiom Space tacked on an additional $175 million to a previously announced capital raise, bringing the oversubscribed round to a total of more than $525 million.

Axiom shared in February that it had secured $350 million in a financing round led by Type One Ventures and Qatar Investment Authority. In the latest release from the company, Axiom reports that Japan-based MUFG Bank Ltd. joined the round as a new investor, in addition to continued participation from existing backers.

The funding will go toward developing the company's commercial space station, known as Axiom Station, and the production of its Axiom Extravehicular Mobility Unit (AxEMU) under its NASA spacesuit contract.

“Investor interest in this round outpaced what we set out to raise, which speaks to the moment we’re in,” Jonathan Cirtain, CEO and president of Axiom Space, said in the news release. “Our partners see what is possible in low-Earth orbit, and they see who is positioned to lead it.”

Axiom announced last month that it planned to open a Japanese subsidiary July 1. Earlier this week, it also shared plans to establish Axiom Space Switzerland, a wholly owned subsidiary based in Lucerne that is also expected to begin operations this summer.

The Switzerland subsidiary aims to establish Axiom's presence in Europe and help it partner with the European Space Agency and other space organizations and companies on the continent.

“Europe is a founding leader in the creation of the commercial space economy, and Switzerland is uniquely positioned to convene the government agencies, research institutions, and industrial entities that will shape its next decade,” Cirtain added in a separate release. “Axiom Space Switzerland facilitates the scaling of development and deployment of the infrastructure that will succeed the International Space Station.”